希腊儿童终末期肾病的成本分析。

Cost Analysis of End-Stage Renal Disease in Pediatric Patients in Greece.

作者信息

Ntais Christos, Loizou Konstantina, Panagiotakis Costas, Kontodimopoulos Nikolaos, Fanourgiakis John

机构信息

Epidemiology Program, School of Science & Technology, Hellenic Open University, 26335 Patras, Greece.

Healthcare Management Program, School of Social Sciences, Hellenic Open University, 26335 Patras, Greece.

出版信息

Healthcare (Basel). 2024 Oct 18;12(20):2074. doi: 10.3390/healthcare12202074.

DOI:10.3390/healthcare12202074

PMID:39451489

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508117/

Abstract

BACKGROUND/OBJECTIVES: The cost resulting from peritoneal dialysis (PD), conventional hemodialysis (HD) and online hemodiafiltration (OL-HDF) in pediatric patients with end-stage renal disease (ESRD) has not been estimated to date in Greece. The present single-center retrospective study aimed to estimate the mean annual cost of the above methods, as well as the individual components of this cost.

METHODS

Twenty pediatric patients undergoing the three different methods of renal replacement therapy were included in this study. Their mean total annual cost was estimated by the method of micro-costing and the bottom-up approach.

RESULTS

The mean total annual cost for PD patients (n = 7) was estimated at EUR 56,676.04; for conventional HD patients (n = 9), it was EUR 39,786.86; and for OL-HDF patients (n = 4), it was EUR 43,894.73. The PD method was found to be more expensive than the other two methods ( < 0.001 vs. conventional HD and = 0.024 vs. OL-HDF). PD consumables used for daily application had the greatest contribution to the total annual cost. The total mean annual cost in the groups of patients undergoing HD and OL-HDF did not differ significantly ( = 0.175). The total operating cost of the renal dialysis unit had the greatest contribution to the total mean annual costs of both the conventional HD and OL-HDF techniques.

CONCLUSIONS

This cost analysis provides useful information to healthcare policymakers who make decisions about the treatment of children with ESRD.

摘要

背景/目的：希腊至今尚未估算终末期肾病（ESRD）患儿接受腹膜透析（PD）、传统血液透析（HD）和在线血液透析滤过（OL-HDF）的费用。本单中心回顾性研究旨在估算上述治疗方法的年均费用及其各项组成部分。

方法

本研究纳入了20例接受三种不同肾脏替代治疗方法的患儿。采用微观成本核算和自下而上的方法估算其年均总费用。

结果

PD组（n = 7）患儿的年均总费用估计为56,676.04欧元；传统HD组（n = 9）为39,786.86欧元；OL-HDF组（n = 4）为43,894.73欧元。结果发现，PD治疗方法比其他两种方法更昂贵（与传统HD相比，< 0.001；与OL-HDF相比， = 0.024）。每日使用的PD耗材对年均总费用的贡献最大。接受HD和OL-HDF治疗的患儿组年均总费用无显著差异（ = 0.175）。肾透析单元的总运营成本对传统HD和OL-HDF技术的年均总费用贡献最大。